112
Views
1
CrossRef citations to date
0
Altmetric
Article Commentary

Achieving zero asthma-related hospitalisations in the world´s first SABA-free Asthma Center in Argentina

, MDORCID Icon, , MD & , MD
Pages 1057-1060 | Received 24 Aug 2022, Accepted 13 Oct 2022, Published online: 25 Oct 2022

References

  • Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention (2021 update). Available from: https://ginasthma.org/wp-content/uploads/2021/05/GINA-Main-Report-2021-V2-WMS.pdf [last accessed 12 November 2021].
  • Kaplan A, Mitchell PD, Cave AJ, Gagnon R, Foran V, Ellis AK. Effective asthma management: Is it time to let the AIR out of SABA? J Clin Med. 2020;9(4):921. doi:10.3390/jcm9040921.
  • Nwaru BI, Ekström M, Hasvold P, Wiklund F, Telg G, Janson C. Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme. Eur Respir J. 2020;55(4):1901872. doi:10.1183/13993003.01872-2019.
  • Molfino NA, Nannini LJ, Martelli AN, Slutsky AS. Respiratory arrest in near-fatal asthma. N Engl J Med. 1991;324(5):285–288. doi:10.1056/NEJM199101313240502.
  • Molfino NA, Nannini LJ, Rebuck AS, Slutsky AS. The fatality-prone asthmatic patient: follow-up study after near-fatal attacks. Chest. 1992;101(3):621–623. doi:10.1378/chest.101.3.621.
  • Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention; 2019. https://ginasthma.org/wp-content/uploads/2019/06/GINA-2019-main-report-June-2019-wms.pdf [last accessed 12 November 2021].
  • Choo-Kang YF, Simpson WT, Grant IW. Controlled comparison of the bronchodilator effects of three β-adrenergic stimulant drugs administered by inhalation to patients with asthma. Br Med J. 1969;2(5652):287–289. doi:10.1136/bmj.2.5652.287.
  • Dennis SM, Sharp SJ, Vickers MR, Frost CD, Crompton GK, Barnes PJ, Lee TH. Regular inhaled salbutamol and asthma control: the TRUST randomised trial. Lancet. 2000;355(9216):1675–1679. doi:10.1016/S0140-6736(00)02238-8.
  • Haahtela T, Tuomisto LE, Pietinalho A, Klaukka T, Erhola M, Kaila M, Nieminen MM, Kontula E, Laitinen LA. A 10 year asthma programme in Finland: major change for the better. Thorax. 2006;61(8):663–670. doi:10.1136/thx.2005.055699.
  • Kauppi P, Peura S, Salimäki J, Järvenpää S, Linna M, Haahtela T. Reduced severity and improved control of self-reported asthma in Finland during 2001-2010. Asia Pac Allergy. 2015;5(1):32–39. doi:10.5415/apallergy.2015.5.1.32.
  • Chan AHY, Katzer CB, Horne R, Haughney J, Correia de Sousa J, Williams S, Kaplan A. SABA Reliance Questionnaire (SRQ): identifying patient beliefs underpinning reliever overreliance in asthma. J Allergy Clin Immunol Pract. 2020;8(10):3482–3489 e3481. doi:10.1016/j.jaip.2020.07.014.
  • Nannini LJ, Neumayer NS, Brandan N, Fernandez OM, Flores DM. Asthma-related hospitalizations after implementing SABA-free asthma management with a maintenance and anti-inflammatory reliever regimen. Eur Clin Respir J. 2022;9(1):2110706. doi:10.1080/20018525.2022.2110706.
  • O'Byrne PM, Bisgaard H, Godard PP, Pistolesi M, Palmqvist M, Zhu Y, Ekström T, Bateman ED. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med. 2005;171(2):129–136. doi:10.1164/rccm.200407-884OC.
  • Hatter L, Bruce P, Braithwaite I, Holliday M, Fingleton J, Weatherall M, Beasley R. ICS-formoterol reliever versus ICS and SABA reliever in asthma: a systematic review and meta-analysis. ERJ Open Res. 2021;7(1):2020. doi:10.1183/23120541.00701-2020.
  • Rodrigo GJ, Plaza Moral V, Forns SB, Castro-Rodríguez JA, de Diego Damiá A, Cortés SL, Moreno CM, Nannini LJ, Neffen H, Salas J, et al. Guía ALERTA 2. América Latina y España: Recomendaciones para la prevención y el Tratamiento de la exacerbación Asmática. Arch Bronconeumol. 2010;46:2–20. doi:10.1016/S0300-2896(10)70041-7.
  • Ankerst J, Persson G, Weibull E. Tolerability of a high dose of budesonide/formoterol in a single inhaler in patients with asthma. Pulm Pharmacol Ther. 2003;16(3):147–151. doi:10.1016/S1094-5539(03)00004-X.
  • Balanag VM, Yunus F, Yang PC, Jorup C. Efficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthma. Pulm Pharmacol Ther. 2006;19(2):139–147. doi:10.1016/j.pupt.2005.04.009.
  • Edmonds ML, Milan SJ, Camargo CA, Jr, Pollack CV, Rowe BH. Early use of inhaled corticosteroids in the emergency department treatment of acute asthma. Cochrane Database Syst Rev. 2012;12(12):CD002308. doi:10.1002/14651858.CD002308.pub2. PMID: 23235589; PMCID: PMC6513646.
  • Nannini LJ. Treat to target approach for asthma. J Asthma. 2020;57(6):687–690. doi:10.1080/02770903.2019.1591443.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.